Titre : Jonctions intercellulaires

Jonctions intercellulaires : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Jonctions intercellulaires : Questions médicales les plus fréquentes", "headline": "Jonctions intercellulaires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Jonctions intercellulaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-17", "dateModified": "2026-04-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Jonctions intercellulaires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Structures de la membrane cellulaire", "url": "https://questionsmedicales.fr/mesh/D021961", "about": { "@type": "MedicalCondition", "name": "Structures de la membrane cellulaire", "code": { "@type": "MedicalCode", "code": "D021961", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Jonctions adhérentes", "alternateName": "Adherens Junctions", "url": "https://questionsmedicales.fr/mesh/D022005", "about": { "@type": "MedicalCondition", "name": "Jonctions adhérentes", "code": { "@type": "MedicalCode", "code": "D022005", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.020" } } }, { "@type": "MedicalWebPage", "name": "Desmosomes", "alternateName": "Desmosomes", "url": "https://questionsmedicales.fr/mesh/D003896", "about": { "@type": "MedicalCondition", "name": "Desmosomes", "code": { "@type": "MedicalCode", "code": "D003896", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.297" } } }, { "@type": "MedicalWebPage", "name": "Jonctions communicantes", "alternateName": "Gap Junctions", "url": "https://questionsmedicales.fr/mesh/D017629", "about": { "@type": "MedicalCondition", "name": "Jonctions communicantes", "code": { "@type": "MedicalCode", "code": "D017629", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.471" } } }, { "@type": "MedicalWebPage", "name": "Plasmodesmes", "alternateName": "Plasmodesmata", "url": "https://questionsmedicales.fr/mesh/D031425", "about": { "@type": "MedicalCondition", "name": "Plasmodesmes", "code": { "@type": "MedicalCode", "code": "D031425", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.625" } } }, { "@type": "MedicalWebPage", "name": "Synapses", "alternateName": "Synapses", "url": "https://questionsmedicales.fr/mesh/D013569", "about": { "@type": "MedicalCondition", "name": "Synapses", "code": { "@type": "MedicalCode", "code": "D013569", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.780" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Synapses électriques", "alternateName": "Electrical Synapses", "url": "https://questionsmedicales.fr/mesh/D054351", "about": { "@type": "MedicalCondition", "name": "Synapses électriques", "code": { "@type": "MedicalCode", "code": "D054351", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.780.180" } } }, { "@type": "MedicalWebPage", "name": "Synapse neuro-effectrice", "alternateName": "Neuroeffector Junction", "url": "https://questionsmedicales.fr/mesh/D009451", "about": { "@type": "MedicalCondition", "name": "Synapse neuro-effectrice", "code": { "@type": "MedicalCode", "code": "D009451", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.780.550" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Jonction neuromusculaire", "alternateName": "Neuromuscular Junction", "url": "https://questionsmedicales.fr/mesh/D009469", "about": { "@type": "MedicalCondition", "name": "Jonction neuromusculaire", "code": { "@type": "MedicalCode", "code": "D009469", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.780.550.550" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Plaque terminale motrice", "alternateName": "Motor Endplate", "url": "https://questionsmedicales.fr/mesh/D009045", "about": { "@type": "MedicalCondition", "name": "Plaque terminale motrice", "code": { "@type": "MedicalCode", "code": "D009045", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.780.550.550.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Plaque terminale motrice", "alternateName": "Motor Endplate", "url": "https://questionsmedicales.fr/mesh/D009045", "about": { "@type": "MedicalCondition", "name": "Plaque terminale motrice", "code": { "@type": "MedicalCode", "code": "D009045", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.780.550.550.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Jonction neuromusculaire", "alternateName": "Neuromuscular Junction", "url": "https://questionsmedicales.fr/mesh/D009469", "about": { "@type": "MedicalCondition", "name": "Jonction neuromusculaire", "code": { "@type": "MedicalCode", "code": "D009469", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.780.550.550" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Plaque terminale motrice", "alternateName": "Motor Endplate", "url": "https://questionsmedicales.fr/mesh/D009045", "about": { "@type": "MedicalCondition", "name": "Plaque terminale motrice", "code": { "@type": "MedicalCode", "code": "D009045", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.780.550.550.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Plaque terminale motrice", "alternateName": "Motor Endplate", "url": "https://questionsmedicales.fr/mesh/D009045", "about": { "@type": "MedicalCondition", "name": "Plaque terminale motrice", "code": { "@type": "MedicalCode", "code": "D009045", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.780.550.550.500" } } }, { "@type": "MedicalWebPage", "name": "Densité post-synaptique", "alternateName": "Post-Synaptic Density", "url": "https://questionsmedicales.fr/mesh/D057907", "about": { "@type": "MedicalCondition", "name": "Densité post-synaptique", "code": { "@type": "MedicalCode", "code": "D057907", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.780.800.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Jonctions serrées", "alternateName": "Tight Junctions", "url": "https://questionsmedicales.fr/mesh/D019108", "about": { "@type": "MedicalCondition", "name": "Jonctions serrées", "code": { "@type": "MedicalCode", "code": "D019108", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.149.165.420.820" } } } ], "about": { "@type": "MedicalCondition", "name": "Jonctions intercellulaires", "alternateName": "Intercellular Junctions", "code": { "@type": "MedicalCode", "code": "D007365", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Lidia Jimenez", "url": "https://questionsmedicales.fr/author/Lidia%20Jimenez", "affiliation": { "@type": "Organization", "name": "Department of Physiology, Biophysics and Neurosciences, CINVESTAV-IPN, CDMX C.P. Mexico City 07360, Mexico." } }, { "@type": "Person", "name": "Marcelino Cereijido", "url": "https://questionsmedicales.fr/author/Marcelino%20Cereijido", "affiliation": { "@type": "Organization", "name": "Department of Physiology, Biophysics and Neurosciences, CINVESTAV-IPN, CDMX C.P. Mexico City 07360, Mexico." } }, { "@type": "Person", "name": "Arturo Ponce", "url": "https://questionsmedicales.fr/author/Arturo%20Ponce", "affiliation": { "@type": "Organization", "name": "Department of Physiology, Biophysics and Neurosciences, CINVESTAV-IPN, CDMX C.P. Mexico City 07360, Mexico." } }, { "@type": "Person", "name": "Paul L Sorgen", "url": "https://questionsmedicales.fr/author/Paul%20L%20Sorgen", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA. Electronic address: psorgen@unmc.edu." } }, { "@type": "Person", "name": "Javier Cervera", "url": "https://questionsmedicales.fr/author/Javier%20Cervera", "affiliation": { "@type": "Organization", "name": "Dept. Termodinàmica, Facultat de Física, Universitat de València, E-46100, Burjassot, Spain. Electronic address: javier.cervera@uv.es." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial.", "datePublished": "2024-03-08", "url": "https://questionsmedicales.fr/article/38457083", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10120-024-01471-z" } }, { "@type": "ScholarlyArticle", "name": "The Short-Term and Long-Term Outcomes of Laparoscopy-Assisted Proximal Gastrectomy with Double-Tract Reconstruction versus Laparoscopy-Assisted Total Gastrectomy with Roux-en-Y Reconstruction for Adenocarcinoma of the Esophagogastric Junction: A Multicenter Study Based on Propensity Score Matching Analysis.", "datePublished": "2024-05-27", "url": "https://questionsmedicales.fr/article/38882392", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2024/5517459" } }, { "@type": "ScholarlyArticle", "name": "Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415).", "datePublished": "2023-06-19", "url": "https://questionsmedicales.fr/article/37337155", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-023-11004-z" } }, { "@type": "ScholarlyArticle", "name": "Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study).", "datePublished": "2024-01-19", "url": "https://questionsmedicales.fr/article/38243037", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10120-024-01467-9" } }, { "@type": "ScholarlyArticle", "name": "Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.", "datePublished": "2024-06-18", "url": "https://questionsmedicales.fr/article/38906161", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/S2468-1253(24)00156-0" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Structures cellulaires", "item": "https://questionsmedicales.fr/mesh/D022082" }, { "@type": "ListItem", "position": 4, "name": "Membrane cellulaire", "item": "https://questionsmedicales.fr/mesh/D002462" }, { "@type": "ListItem", "position": 5, "name": "Structures de la membrane cellulaire", "item": "https://questionsmedicales.fr/mesh/D021961" }, { "@type": "ListItem", "position": 6, "name": "Jonctions intercellulaires", "item": "https://questionsmedicales.fr/mesh/D007365" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Jonctions intercellulaires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Jonctions intercellulaires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-04-28", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Jonctions intercellulaires", "description": "Comment diagnostiquer une dysfonction des jonctions intercellulaires ?\nQuels examens sont utilisés pour évaluer les jonctions intercellulaires ?\nLes tests génétiques sont-ils utiles pour les jonctions intercellulaires ?\nQuels signes cliniques indiquent une atteinte des jonctions intercellulaires ?\nPeut-on utiliser des biomarqueurs pour diagnostiquer des troubles des jonctions ?", "url": "https://questionsmedicales.fr/mesh/D007365?page=204#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Jonctions intercellulaires", "description": "Quels symptômes sont associés à des jonctions intercellulaires défectueuses ?\nLes troubles des jonctions intercellulaires causent-ils des douleurs ?\nComment les dysfonctionnements affectent-ils la peau ?\nLes troubles des jonctions intercellulaires affectent-ils le système immunitaire ?\nY a-t-il des symptômes neurologiques liés aux jonctions intercellulaires ?", "url": "https://questionsmedicales.fr/mesh/D007365?page=204#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Jonctions intercellulaires", "description": "Comment prévenir les troubles des jonctions intercellulaires ?\nLes antioxydants jouent-ils un rôle dans la prévention ?\nL'hydratation est-elle importante pour les jonctions intercellulaires ?\nLes exercices physiques peuvent-ils renforcer les jonctions ?\nFaut-il éviter certains aliments pour protéger les jonctions ?", "url": "https://questionsmedicales.fr/mesh/D007365?page=204#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Jonctions intercellulaires", "description": "Quels traitements sont disponibles pour les troubles des jonctions ?\nLa thérapie génique peut-elle aider les dysfonctionnements des jonctions ?\nLes traitements topiques sont-ils efficaces pour les problèmes cutanés ?\nPeut-on utiliser des probiotiques pour améliorer les jonctions intestinales ?\nLes interventions chirurgicales sont-elles nécessaires pour certains troubles ?", "url": "https://questionsmedicales.fr/mesh/D007365?page=204#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Jonctions intercellulaires", "description": "Quelles complications peuvent survenir avec des jonctions défectueuses ?\nLes troubles des jonctions peuvent-ils mener à des cancers ?\nComment les troubles des jonctions affectent-ils la cicatrisation ?\nLes complications cardiovasculaires sont-elles liées aux jonctions ?\nLes troubles des jonctions peuvent-ils affecter la fertilité ?", "url": "https://questionsmedicales.fr/mesh/D007365?page=204#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Jonctions intercellulaires", "description": "Quels facteurs de risque sont associés aux troubles des jonctions ?\nL'âge est-il un facteur de risque pour les dysfonctionnements des jonctions ?\nLe tabagisme influence-t-il les jonctions intercellulaires ?\nLe stress peut-il affecter les jonctions intercellulaires ?\nUne alimentation déséquilibrée est-elle un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D007365?page=204#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des jonctions intercellulaires ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests histologiques et des analyses d'imagerie peuvent révéler des anomalies." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer les jonctions intercellulaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'immunofluorescence et la microscopie électronique sont couramment utilisés." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour les jonctions intercellulaires ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent identifier des mutations affectant les protéines des jonctions." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une atteinte des jonctions intercellulaires ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme l'inflammation ou des troubles de la perméabilité peuvent apparaître." } }, { "@type": "Question", "name": "Peut-on utiliser des biomarqueurs pour diagnostiquer des troubles des jonctions ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains biomarqueurs peuvent indiquer des dysfonctionnements des jonctions." } }, { "@type": "Question", "name": "Quels symptômes sont associés à des jonctions intercellulaires défectueuses ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent inflammation, œdème et troubles de la communication cellulaire." } }, { "@type": "Question", "name": "Les troubles des jonctions intercellulaires causent-ils des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs peuvent survenir en raison de l'inflammation et de la dégradation tissulaire." } }, { "@type": "Question", "name": "Comment les dysfonctionnements affectent-ils la peau ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent entraîner des maladies cutanées comme l'eczéma ou le psoriasis." } }, { "@type": "Question", "name": "Les troubles des jonctions intercellulaires affectent-ils le système immunitaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent compromettre la réponse immunitaire et augmenter les infections." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques liés aux jonctions intercellulaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles neurologiques peuvent survenir, affectant la communication neuronale." } }, { "@type": "Question", "name": "Comment prévenir les troubles des jonctions intercellulaires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à maintenir leur fonction." } }, { "@type": "Question", "name": "Les antioxydants jouent-ils un rôle dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antioxydants peuvent protéger les cellules et les jonctions contre les dommages." } }, { "@type": "Question", "name": "L'hydratation est-elle importante pour les jonctions intercellulaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hydratation aide à maintenir l'intégrité des jonctions cellulaires." } }, { "@type": "Question", "name": "Les exercices physiques peuvent-ils renforcer les jonctions ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier favorise la santé cellulaire et l'intégrité des jonctions." } }, { "@type": "Question", "name": "Faut-il éviter certains aliments pour protéger les jonctions ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, limiter les aliments transformés et riches en sucres peut être bénéfique." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles des jonctions ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments anti-inflammatoires et des thérapies ciblées." } }, { "@type": "Question", "name": "La thérapie génique peut-elle aider les dysfonctionnements des jonctions ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie génique vise à corriger les mutations affectant les jonctions." } }, { "@type": "Question", "name": "Les traitements topiques sont-ils efficaces pour les problèmes cutanés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements topiques peuvent améliorer l'intégrité des jonctions cutanées." } }, { "@type": "Question", "name": "Peut-on utiliser des probiotiques pour améliorer les jonctions intestinales ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les probiotiques peuvent renforcer les jonctions serrées dans l'intestin." } }, { "@type": "Question", "name": "Les interventions chirurgicales sont-elles nécessaires pour certains troubles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, une chirurgie peut être requise pour réparer des tissus endommagés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des jonctions défectueuses ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des maladies inflammatoires et des infections récurrentes." } }, { "@type": "Question", "name": "Les troubles des jonctions peuvent-ils mener à des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dysfonctionnements peuvent augmenter le risque de certains cancers." } }, { "@type": "Question", "name": "Comment les troubles des jonctions affectent-ils la cicatrisation ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent retarder la cicatrisation des plaies en perturbant la communication cellulaire." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles liées aux jonctions ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des jonctions défectueuses peuvent contribuer à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les troubles des jonctions peuvent-ils affecter la fertilité ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies peuvent perturber la fonction reproductive et la fertilité." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés aux troubles des jonctions ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'inflammation chronique et le stress oxydatif augmentent le risque." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour les dysfonctionnements des jonctions ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter la structure et la fonction des jonctions intercellulaires." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il les jonctions intercellulaires ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut endommager les jonctions et augmenter le risque de maladies." } }, { "@type": "Question", "name": "Le stress peut-il affecter les jonctions intercellulaires ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber la fonction des jonctions et la santé cellulaire." } }, { "@type": "Question", "name": "Une alimentation déséquilibrée est-elle un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées et en sucres peut nuire aux jonctions." } } ] } ] }

Sources (2035 au total)

Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial.

It remains unclear whether addition of docetaxel to the combination of a platinum and fluoropyrimidine could provide more clinical benefits than doublet chemotherapies in the perioperative treatment f... Patients with cT3-4 N... From Aug, 2015 to Dec, 2019,154 patients were enrolled and 147 patients included in final analysis, with a median age of 60 (26-73) years. DOS resulted in significantly higher MPR (25.4 vs. 11.8%, P =... Perioperative DOS improved MPR significantly and tended to produce longer PFS compared to SOX in LAG/GEJ cancer in Asia, and might be considered as a preferred option for perioperative chemotherapy an...

The Short-Term and Long-Term Outcomes of Laparoscopy-Assisted Proximal Gastrectomy with Double-Tract Reconstruction versus Laparoscopy-Assisted Total Gastrectomy with Roux-en-Y Reconstruction for Adenocarcinoma of the Esophagogastric Junction: A Multicenter Study Based on Propensity Score Matching Analysis.

To compare the antireflux effect, long-term nutritional levels, and quality of life (QoL) between laparoscopy-assisted proximal gastrectomy with double-tract reconstruction (LPG-DTR) and laparoscopy-a... This multicenter retrospective cohort study collected clinicopathological and follow-up data of AEG patients from January 2016 to January 2021 at five high-volume surgery centers. The study included p... A total of 151 consecutive patients underwent either LPG-DTR or LTG-RY. After PSM, 50 patients from each group were included in the analysis. The frequency of reflux esophagitis and Clavien-Dindo clas... Both LPG-DTR and LTG-RY are safe and feasible methods for digestive tract reconstruction in patients with AEG. Both methods have similar antireflux effects and postoperative QoL. However, LPG-DTR resu...

Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415).

Paclitaxel in combination with ramucirumab is the standard of care second-line therapy in gastro-esophageal adenocarcinoma (GEA). As the number of taxane pretreated patients in the perioperative or fi... The RAMIRIS trial is a randomized, open-label, multicenter phase II/III study comparing treatment of FOLFIRI-Ram (arm A) with paclitaxel and ramucirumab (arm B). The Phase II is already closed with 11... The already completed RAMIRIS phase II demonstrated feasibility and efficacy of FOLFIRI-Ram. Especially docetaxel-pretreated patients seemed to markedly benefit from FOLFIRI-Ram, with favorable respon... NCT03081143 Date of registration: 13.11.2015....

Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study).

This randomized phase II study explored the superiority of trastuzumab plus S-1 plus cisplatin (SP) over SP alone as neoadjuvant chemotherapy (NAC) for HER2-positive resectable gastric cancer with ext... Eligible patients with HER2-positive gastric or esophagogastric junction cancer and extensive lymph node metastasis were randomized to receive three or four courses of preoperative chemotherapy with S... This report elucidates the early endpoints, including pathological findings and safety. The study was terminated early due to slow patient accruals. In total, 46 patients were allocated to arm A (n = ... Trastuzumab can be safely added to platinum-containing doublet chemotherapy as NAC, and it has the potential to contribute to higher antitumor activity against locally advanced, HER2-positive gastric ...

Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.

In Asia, adjuvant chemotherapy after gastrectomy with D2 or more extensive lymph-node dissection is standard treatment for people with pathological stage III gastric or gastro-oesophageal junction (GE... ATTRACTION-5 was a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial conducted at 96 hospitals in Japan, South Korea, Taiwan, and China. Eligible patients were aged between 20 y... Between Feb 1, 2017, and Aug 15, 2019, 755 patients were randomly assigned to receive either adjuvant nivolumab plus chemotherapy (n=377) or adjuvant placebo plus chemotherapy (n=378). 267 (71%) of 37... The results of this trial do not support the addition of nivolumab to postoperative adjuvant therapy for patients with untreated, locally advanced, resectable gastric or GEJ cancer.... Ono Pharmaceutical and Bristol Myers Squibb....